Allogene Therapeutics Inc (ALLO)

Nov 20, 2025

Allogene Therapeutics Inc Stock Analysis and ForecastTop Performing Stocks & Low Risk Investment Trading - earlytimes.in

Nov 20, 2025

Nov 20, 2025

Allogene Therapeutics unveils ALLO-329 to combat autoimmune diseases - Traders Union

Nov 20, 2025

Nov 19, 2025

Analyzing Allogene Therapeutics Inc. with multi timeframe chartsWeekly Stock Report & Fast Moving Trade Plans - newser.com

Nov 19, 2025

Nov 19, 2025

Detecting support and resistance levels for Allogene Therapeutics Inc.Market Movement Recap & Step-by-Step Trade Execution Guides - newser.com

Nov 19, 2025

Nov 19, 2025

[Form 4] Allogene Therapeutics, Inc. Insider Trading Activity - Stock Titan

Nov 19, 2025

Nov 19, 2025

Why Allogene Therapeutics Inc. stock remains on watchlistsPortfolio Return Summary & Risk Adjusted Buy and Sell Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Allogene Therapeutics advances ALLO-329 cell therapy to transform autoimmune care - Traders Union

Nov 19, 2025

Nov 19, 2025

ALLO (Allogene Therapeutics) Construction In Progress : $0.00 Mil (As of Sep. 2025) - GuruFocus

Nov 19, 2025

Nov 19, 2025

Will breakout in Allogene Therapeutics Inc. lead to full recovery2025 Volume Leaders & Free Verified High Yield Trade Plans - newser.com

Nov 19, 2025

Nov 18, 2025

What candlestick patterns are forming on Allogene Therapeutics Inc.Weekly Trend Recap & Reliable Price Breakout Signals - newser.com

Nov 18, 2025

Nov 18, 2025

Allogene Therapeutics at Jefferies Conference: Strategic Advances in CAR-T Therapy - Investing.com Canada

Nov 18, 2025

Nov 17, 2025

VP Beneski Files To Sell 786 Of Allogene Therapeutics Inc [ALLO] - TradingView

Nov 17, 2025

Nov 16, 2025

Applying Elliott Wave Theory to Allogene Therapeutics Inc.July 2025 Analyst Calls & Safe Capital Allocation Plans - newser.com

Nov 16, 2025

Nov 16, 2025

Risk adjusted return profile for Allogene Therapeutics Inc. analyzedQuarterly Trade Report & Low Risk Entry Point Guides - newser.com

Nov 16, 2025

Nov 14, 2025

Allogene Therapeutics CEO advocates cell therapy innovation at Jefferies conference - Traders Union

Nov 14, 2025

Nov 14, 2025

Published on: 2025-11-14 03:15:46 - newser.com

Nov 14, 2025

Nov 14, 2025

How sentiment analysis helps forecast Allogene Therapeutics Inc.2025 Top Gainers & Step-by-Step Trade Execution Guides - newser.com

Nov 14, 2025

Nov 14, 2025

Using AI based signals to follow Allogene Therapeutics Inc.2025 Market Outlook & Momentum Based Trading Ideas - newser.com

Nov 14, 2025

Nov 12, 2025

Published on: 2025-11-12 16:30:24 - newser.com

Nov 12, 2025

Nov 12, 2025

November 2025's Promising Penny Stocks To Watch - simplywall.st

Nov 12, 2025

Nov 12, 2025

Published on: 2025-11-12 02:14:40 - newser.com

Nov 12, 2025

Nov 12, 2025

Allogene Therapeutics (ALLO) Receives a Buy from H.C. Wainwright - The Globe and Mail

Nov 12, 2025

Nov 11, 2025

Analysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO), NeurAxis, Inc. (NRXS) and Celcuity (CELC) - The Globe and Mail

Nov 11, 2025

Nov 11, 2025

Allogene Therapeutics Advances in CAR T Therapy Development - MSN

Nov 11, 2025

Nov 10, 2025

Allogene Therapeutics readies for key healthcare investor conferences - Traders Union

Nov 10, 2025

Nov 10, 2025

Allogene Therapeutics Announces Participation in Upcoming Investor Conferences - The Manila Times

Nov 10, 2025

Nov 10, 2025

Allogene (NASDAQ: ALLO) to join 3 conferences: TD Cowen, Jefferies London, Piper Sandler - Stock Titan

Nov 10, 2025